SARS–CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and Challenges
Review
[키워드] ACE2
acute respiratory distress
Adaptive immune response
angiotensin-converting enzyme 2
Antibody titers
Asymptomatic
CD147
challenge
characterized
cleavage
CLR
Coronavirus disease-19
COVID-19
Cytokine storm syndrome
displaying
domain
dysregulation
Effect
Frame
host immune system
immune antagonism
Immunopathogenesis
immunopathology
immunotherapies
implicated
include
innate immune system
Interaction
life-threatening
mechanism
myeloid
non-structural protein
Novel coronavirus
NRP1
nucleic acid vaccine
opportunity
Other
pathology
peptide
Potential
receptor
reduced
Research
respiratory
SARS-CoV-2
SARS-COV-2 infection
spike glycoprotein
syndrome
Therapeutics
Therapies
therapy
TMPRSS2
Treatment
Vaccine
Vaccines
viral spread
Viral variants
virus
Wuhan, China
[DOI] 10.3390/idr13010013 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/idr13010013 PMC 바로가기 [Article Type] Review